Delivery Order SPE2DB22D2211-SPE2DB25FSBSP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,305.04 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors. This firm fixed-price delivery order is scheduled for completion by July 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,904.63 on August 9, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injectors. This firm fixed-price delivery order, with an ultimate completion date of August 11, 2025, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive capability in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,408.25 on July 28, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This non-competitive delivery order, with a completion date of July 29, 2025, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract utilizes firm fixed pricing and represents a child order under a larger contract vehicle supporting federal medical procurement needs. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,613.98 on September 5, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and a completion date of September 8, 2025. The product will be performed and sourced from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,632.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen injectors on August 6, 2025, with completion expected by August 7, 2025. This is a non-set-aside competitive award placed to the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a relatively small transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio, reflecting the company's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,826.12 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This firm fixed price, competitively awarded delivery order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The contract represents a non-set-aside procurement, indicating open competition among qualified vendors. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, where the place of...
- The Defense Logistics Agency awarded a $8,391.06 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors with an ultimate completion date of August 1, 2025. This firm fixed-price, non-set-aside contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This delivery...
- The Defense Logistics Agency awarded a $6,044.24 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors (0.5 ml). The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. The contract specifies a completion date of July 31, 2025, and lists the place of performance as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $2,123.03 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order, issued without a set-aside designation, represents a competitively awarded pharmaceutical supply transaction supporting federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $7,583.88 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors on April 24, 2025, with completion scheduled for April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a small-value transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's facility in...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBSPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,346.43 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 ml pen injectors on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under a larger indefinite delivery contract vehicle. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 7/28/25 |